Trademarkia Logo

Canada

C$
Trademark Search in Canada
VERICI DX

View On IC.GC.CA

VERICI DX
REGISTERED

on 5 Jan 2024

Last Applicant/ Owned by

RENALYTIX AI INC.

1460 BroadwayNew York NY 10036

US

Serial Number

2085612 filed on 6th Jan 2021

Registration Number

TMA1216893 registered on 5th Jan 2024

Registration expiry Date

6th Jan 2031

Correspondent Address

SMART & BIGGAR LP

1100-150 York StreetToronto

ONTARIO

CA

M5H3S5

VERICI DX

Trademark usage description

medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney Read More

Classification Information

Class [005]
Medical diagnostic blood or biopsy testing reagents and assays for advanced next-generation sequencing science for creating immune profiling of kidney transplant recipients for predicting and identifying risk of graft rejection; medical diagnostic reagents consisting primarily of reagents for use in disease testing and prediction; nucleic acid sequences and diagnostic chemical reagents for diagnosing kidney diseases.

Classification kind code

11

Class [010]
Blood test collection kit comprised of blood collection tube and bag, and holder for medical sample tubes, for predicting and identifying the risk of graft injury and graft loss in kidney transplant recipients.

Classification kind code

11

Class [042]
Development of new technology for others in the field of medical devices and medical diagnostic apparatuses; research, development and consultation related thereto in the field of medical devices and medical diagnostic apparatuses through the use of artificial intelligence; laboratory research in the field of kidney transplant; medical research services; computer software development; providing temporary use of on-line non-downloadable software and software applications using artificial intelligence for medical analysis.

Classification kind code

11

Class [044]
Medical profile and medical record analysis designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; medical analysis services for predicting and identifying risk of graft rejection in kidney transplant patients.

Classification kind code

11

Mark Details

Serial Number

2085612

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 15th Jun 2022		Search Recorded
Submitted for opposition 20
on 15th Jun 2022		Examiner's First Report
Submitted for opposition 223
on 15th Jun 2022		Total Provisional Refusal
Submitted for opposition 256
on 20th Dec 2021		Notification of Possible Opposition Sent
Submitted for opposition 48
on 27th Jul 2021		Agent Changed
Submitted for opposition 257
on 18th Feb 2021		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 17th Feb 2021		Created
Submitted for opposition 31
on 17th Feb 2021		Formalized
Submitted for opposition 228
on 6th Jan 2021		International Registration
Submitted for opposition 30
on 6th Jan 2021		Filed